Rabies prevention local action partnering organizations Rabies prevention local action partnering organizations Global rabies prevention needs local action. Together with partnering organizations, we’re using pilot projects to find the right approach.
BIVF funding more than doubled to 250 M€ BIVF funding more than doubled to 250 M€ Boehringer Ingelheim increases funding for its corporate venture fund, the Boehringer Ingelheim Venture Fund (BIVF), from EUR 100 to 250 million
Heart murmur in dogs: symptoms and how to treat it Heart murmur in dogs: symptoms and how to treat it Monitoring your dog’s heart can save its life
Ivan Blanarik Therapeutic Area Head Respiratory Ivan Blanarik Therapeutic Area Head Respiratory Ivan Blanarik, Therapeutic Area Head Respiratory at Boehringer Ingelheim
Retinal health: All eyes on vision loss Retinal health: All eyes on vision loss Discover how we want to prevent vision loss caused by diabetic retinopathy and other retinal diseases
SPEVIGO CHMP positive opinion new indications SPEVIGO CHMP positive opinion new indications CHMP adopts positive opinion recommending approval of new and expanded indications for SPEVIGO®
Spiolto® Respimat® Spiolto® Respimat® Maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
commitments to sustainable development commitments to sustainable development On One Health Day, Boehringer Ingelheim shares an update on its strategic approach to sustainability for employees, partners and wider communities
Phase II trials for patients with bronchiectasis Phase II trials for patients with bronchiectasis Bronchiectasis is a chronically progressive pulmonary disease. Boehringer Ingelheim investigates a potential new treatment option in two Phase II trials.
Vetera Vetera For vaccination of healthy horses as an aid in the prevention of diseases caused by the included antigens (US and Canada only).
A Unique Bond: friends in need A Unique Bond: friends in need After suffering from a stroke, Phil’s connection with Valle helped change his life
Soaring to save lives Soaring to save lives Tackling health disparities through drone delivery of vaccines animals and livestock living in underserved communities
Action makes the difference in poultry farms Action makes the difference in poultry farms Farmers, be on the lookout to protect chickens against the ILT virus!
Our-position Our-position Potential access to selected medications for appropriate patients with serious, life-threatening diseases unable to participate in a clinical trial
Prascend Prascend Symptomatic treatment of clinical signs associated with pituitary pars intermedia dysfunction (PPID; also known as equine Cushing’s disease).
Advancing health equity for rural doctors in Mexico Advancing health equity for rural doctors in Mexico Our virtual sales team helps doctors stay informed through digital education about the latest treatments, regardless of their location
Retinal Health: Meet the Scientists Retinal Health: Meet the Scientists We aim to prevent, treat, and restore vision loss. Delve behind the lab to see our scientists spearheading research to address retinopathies.
Behind the Lab Behind the Lab Delve behind the lab to see how our Retinal Health scientists are spearheading research into novel therapeutics to treat retinopathies.
InSensitive Content: impact on the GPP patient community InSensitive Content: impact on the GPP patient community Understand why the patient community should be able to post and consume visual content related to generalized pustular psoriasis.
Prevexxion™ RN Prevexxion™ RN The vaccine is recommended for in ovo vaccination of 18 to 19-day-old embryonated chicken eggs to protect against the very virulent Marek’s disease.